How NIH’s Financial Conflict of Interest Rules Are Expanding Institutional Risk in 2026
NIH’s financial conflict of interest rules are placing greater pressure on institutions to strengthen disclosure oversight and compliance systems.
On Wednesdays, sharing best practices, tips, anything that shows our expertise.
NIH’s financial conflict of interest rules are placing greater pressure on institutions to strengthen disclosure oversight and compliance systems.
NIH’s new eRA Commons account consolidation feature aims to simplify login management and reduce administrative burden across research institutions.
Grow your startup without giving up IP or ownership rights! 💡📈 Discover strategies like bootstrapping, non-dilutive funding, and strategic partnerships. 🚀
NIH is reinforcing reproducibility expectations, shifting how reviewers assess credibility and forcing applicants to rethink how rigor is built into study design.
AI speeds up grant writing, but misalignment with agency expectations remains the quiet reason many strong proposals fail to secure funding.
AI strengthens proposals only when ownership is clear. Reviewers focus on IP, data rights, and commercialization risk, not technical buzzwords.
SBIR resubmissions are still allowed, but success depends on correcting reviewer concerns, not simply revising language or adding more detail.
The new SBIR/STTR TABA rules change who can use funds, how they can be used, and why proposal strategy matters more.
SBIR is reauthorized. Heightened oversight makes independent evaluation a strategic advantage for applicants in upcoming funding cycles
NIH’s “competitive but not discussed” designation reflects review compression, not automatic rejection, and still carries real funding potential.